COVID-19 and Acute Pancreatitis: Not Increased Risk but Reduced Care

被引:0
作者
Cevolani, Michele [1 ,2 ]
Ferronato, Marco [1 ,2 ]
Lizzio, Chiara Elide [1 ,2 ]
Elia, Eleonora [1 ,2 ]
Marini, Desy [1 ,2 ]
Mazzotta, Elena [1 ,2 ]
Ricci, Claudio [1 ,2 ]
Casadei, Riccardo [1 ,2 ]
机构
[1] Univ Bologna, Dept Internal Med & Surg DIMEC, Alma Mater Studiorum, Via Massarenti 9, I-40138 Bologna, Italy
[2] Univ Bologna, IRCCS Azienda Osped, Policlin St Orsola, Via Albertoni 15, I-40138 Bologna, Italy
关键词
acute pancreatitis; SARS-CoV-2; COVID-19; idiopathic;
D O I
10.3390/gastroent14040039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: Over the last few years, SARS-CoV-2 has been reported as a possible cause of acute pancreatitis (AP), but whether it is a relevant clinical-epidemiological entity is still a matter of debate. We aim to evaluate the epidemiological characteristics of AP during the first year of the COVID pandemic (2020) and compare them with the pre-COVID period (2008-2019) to identify any differences and clarify a potential causative role of SARS-CoV-2. Methods: We used a monocentric retrospective study of 132 AP patients during 2020 and 1987 AP patients during 2008-2019. Diagnosis and severity were classified according to the revised Atlanta criteria. Propensity score matching was performed according to clinical-epidemiological features, and outcome analysis was performed on two subgroups of 109 patients. Results: The total number of AP cases in 2020 is one of the lowest in the last 13 years (132 cases, median 161, IQR 146-183). No major epidemiological differences were noted. During 2020, we observed a significant modification of the distribution of etiologies (p < 0.001), mainly based on a decrease in biliary forms (59.6% vs. 43.2%) and an increase in alcoholic forms (6.9% vs. 12.9%). Idiopathic forms remain unchanged (20.5% vs. 21.9%). The proportion of AP of idiopathic etiology and SARS-CoV-2 infection was 0.008%. There were no differences in terms of severity distribution (p = 0.127), length of stay (p = 0.916), need for ICU (p = 0.139), or mortality (p = 0.462). Even among statistically matched groups, there were no differences between the length of stay (9 vs. 10 days, p = 0.890), need for ICU admission (1.8% vs. 3.7%, p = 0.683), or in-hospital mortality (0 vs. 1.8%, p = 0.342). Conclusions: The lower AP diagnoses indicate delayed and likely missed diagnoses, probably because of both hesitancy and organizational problems during the pandemic. The unchanged proportion of idiopathic forms supports the hypothesis that SARS-CoV-2 is not an AP trigger.
引用
收藏
页码:553 / 563
页数:11
相关论文
共 36 条
  • [1] COVID-19 presenting as acute pancreatitis
    Aloysius, Mark M.
    Thatti, Ashwin
    Gupta, Anjalika
    Sharma, Nishant
    Bansal, Pardeep
    Goyal, Hemant
    [J]. PANCREATOLOGY, 2020, 20 (05) : 1026 - 1027
  • [2] Aziz Ahmed Ali, 2023, Cureus, V15, pe38764, DOI 10.7759/cureus.38764
  • [3] Drug-induced acute pancreatitis: An evidence-based review
    Badalov, Nison
    Baradarian, Robin
    Iswara, Kadirawel
    Li, Jianjun
    Steinberg, William
    Tenner, Scott
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) : 648 - 661
  • [4] Causes of acute and recurrent pancreatitis - Clinical considerations and clues to diagnosis
    Bank, S
    Indaram, A
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (03) : 571 - +
  • [5] Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus
    Banks, Peter A.
    Bollen, Thomas L.
    Dervenis, Christos
    Gooszen, Hein G.
    Johnson, Colin D.
    Sarr, Michael G.
    Tsiotos, Gregory G.
    Vege, Santhi Swaroop
    [J]. GUT, 2013, 62 (01) : 102 - 111
  • [6] IAP/APA evidence-based guidelines for the management of acute pancreatitis
    Besselink, Marc
    van Santvoort, Hjalmar
    Freeman, Martin
    Gardner, Timothy
    Mayerle, Julia
    Vege, Santhi Swaroop
    Werner, Jens
    Banks, Peter
    McKay, Colin
    Fernandez-del Castillo, Carlos
    French, Jeremy
    Gooszen, Hein
    Johnson, Colin
    Sarr, Mike
    Takada, Tadahiro
    Windsor, John
    Saluja, Ashok
    Liddle, Rodger
    Papachristou, Georgios
    Singh, Vijay
    Ruenzi, Michael
    Wu, Bechien
    Singh, Vikesh
    Bollen, Thomas
    Morgan, Desiree
    Mortele, Koenraad
    Mittal, Anubhav
    En-qiang, Mao
    de Waele, Jan
    Petrov, Maxim
    Dellinger, Patchen
    Lerch, Markus M.
    Anderson, Roland
    McClave, Stephen
    Hartwig, Werner
    Bruno, Marco
    Oria, Alejandro
    Baron, Todd
    Fagenholz, Peter
    Horvath, Karen
    van Baal, Mark
    Nealon, William
    Andren-Sandberg, Ake
    Bakker, Olaf
    Bassi, Claudio
    Buchler, Markus
    Boermeester, Marja
    Bradley, Ed
    Chari, Suresh
    Charnley, Richard
    [J]. PANCREATOLOGY, 2013, 13 (04) : E1 - E15
  • [7] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Beyerstedt, Stephany
    Casaro, Expedito Barbosa
    Rangel, Erika Bevilaqua
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 905 - 919
  • [8] Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence
    Bruno, Giuseppe
    Fabrizio, Claudia
    Santoro, Carmen R.
    Buccoliero, Giovanni B.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 74 - 75
  • [9] Acute pancreatitis and COVID-19: A literature review
    Correia de Sa, Tiago
    Soares, Carlos
    Rocha, Monica
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (06): : 574 - 584
  • [10] Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease
    Da, Ben L.
    Im, Gene Y.
    Schiano, Thomas D.
    [J]. HEPATOLOGY, 2020, 72 (03) : 1102 - 1108